In this syndrome, a mutation in the protein APC, leads to hyperactivation of the WNT/β-catenin signaling pathway and, in turn, to uncontrolled intestinal cell proliferation and a high risk for the formation of adenocarcinomas. This evidence concerns the gene APC and adenocarcinoma.